Ticker Details
Lineage Cell Therapeutics, Inc.
IPO Date:	April 1, 1992
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$416.89M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.05 | 3.73%
Avg Daily Range (30 D):	$0.05 | 3.13%
Avg Daily Range (90 D):	$0.05 | 2.94%

Institutional Daily Volume
Avg Daily Volume:	.95M
Avg Daily Volume (30 D):	1.07M
Avg Daily Volume (90 D):	1.46M

Trade Size
Avg Trade Size (Sh.):	299
Avg Trade Size (Sh.) (30 D):	209
Avg Trade Size (Sh.) (90 D):	280

Institutional Trades
Total Institutional Trades:	49
Avg Institutional Trade:	$3.82M
Avg Institutional Trade (30 D):	$.55M
Avg Institutional Trade (90 D):	$5.17M
Avg Institutional Trade Volume:	2.83M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.59M
Avg Closing Trade (30 D):	$2.65M
Avg Closing Trade (90 D):	$2.65M
Avg Closing Volume:	4.34M

News

Jan 29, 2026 @ 6:31 PM Longevity Biotech Stocks Surge as $27 Trillion Hea... Source: Prnewswire

Jul 30, 2025 @ 9:07 PM W.P. Carey (WPC) Q2 AFFO Jumps 9.4% Source: Jesterai

Feb 11, 2025 @ 9:45 AM Refrigerated Warehousing Market Revenues to Grow f... Source: Researchandmarkets.Com

Oct 8, 2024 @ 9:00 AM ORBCOMM joins Move to -15°C coalition to promot... Source: Orbcomm

Sep 21, 2024 @ 10:36 PM W.P. Carey: Buy, Sell, or Hold? Source: Courtney Carlsen

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.13	$-.13	$-.02
Diluted EPS	$-.13	$-.13	$-.02
Revenue	$3.68M	$2.77M	$1.5M
Gross Profit			$1.47M
Net Income / Loss	$-29.75M	$-30.36M	$-4.14M
Operating Income / Loss	$-3.79M	$-19.78M	$-6.51M
Cost of Revenue			$.04M
Net Cash Flow	$-1.8M	$-5.57M	$1.99M
PE Ratio